Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Momentum Daytrading - Tricks of the Trade -- Ignore unavailable to you. Want to Upgrade?

To: TATRADER who wrote (859)	3/31/1998 10:39:00 AM
From: Sandra	Read Replies (1) \| Respond to of 2120

NPRO might get some legs, heres the scoop.... 10:13 ET NaPro BioTherapeutics (NPRO) 2 13/16 +5/16: Company issued a patent relating to a novel method of stabilizing formulations of paclitaxel. By receiving the patent, company triggers an additional $3.75 million payment from IVAX, which is approx. equal to company's entire top-line in FY97 ($3.8 mln).